Unique Prostate Cancer Partnership Develops Programs for Survivors

Date Posted: 
2013-03-20

Prostate Cancer Canada (PCC) has established ‘A Survivorship Action Partnership’ (ASAP) to help improve the lives of prostate cancer survivors and their partners, caregivers and family members across Canada.

The network, led by PCC and funded by Movember, met on Feb. 26 and 27 in Vancouver to share ideas and experience, and focus on the business of providing the right support and education to help everyone touched by the diagnosis of prostate cancer and the decisions, actions and outcomes that follow.

This inaugural working meeting included delegates representing 19 clinical, community and academic institutions from across the country as well as survivors and non-medical members of the public.

Dr. Peter Black and Professor Richard Wassersug from the Vancouver Prostate Centre attended as members of both the Prostate Cancer Supportive Care Program being initiated in Vancouver and the national Androgen Deprivation Therapy Working Group, which is a consortium of researchers and clinicians who study ways to help prostate cancer patients and their partners deal with the side effects of hormonal therapy.

The press release with further information is available here.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

PCF BC

Ride to Live 2018 and 50-50 Draw: May 27

The West Coast Motorcycle Ride to Live, raising funds for Prostate Cancer Foundation BC, takes place on Sunday May 27, 2018 in Vancouver, Victoria & the Fraser Valley. Follow the links to join a ride or donate to a rider; or to buy a ticket for a 50/50 draw (BC residents only).

Employment

Work at the Vancouver Prostate Centre

Thursday, January 18, 2018

Discovery of a promising new medication to block "master key" of cancer growth

Dr. Chris Ong
Tuesday, February 20, 2018

Drs. Wyatt and Chi: ctDNA predicts resistance to AR-targeted therapy

VCHRI News article on study of ctDNA predicting resistance to AR-targeted therapy
DNA

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.